Carvedilol 50 mg

DRUG2 trials

Sponsors

Yale University, University of Arizona

Conditions

CAR T-Cell TherapyCell TherapyCocaine DependenceDonor Lymphocyte InfusionHematopoetic Stem Cell TransplantationLeukemiaLymphomaOpiate Dependence

Early Phase 1

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

RecruitingNCT06643221

University of ArizonaCAR T-Cell Therapy, Cell Therapy, Donor Lymphocyte Infusion +3

Start: 2018-01-24End: 2031-05-31Target: 200Updated: 2026-06-05

Unknown Phase

Cocaine Withdrawal and Pharmacotherapy Response

CompletedNCT00566969

Yale UniversityCocaine Dependence, Opiate Dependence

Start: 2007-09-30End: 2013-01-31Updated: 2020-04-02

Related Papers

Exercise-mobilized lymphocytes enhance antibody-based immunotherapy in multiple myeloma through CD16+ NK cell–mediated cytotoxicity

Journal of Translational Medicine2026-03-03

Exercise-Mobilized Lymphocytes Enhance the Function of Cytokine-Induced Memory-like NK-cells Against Myeloid Leukemia.

2026-01-15